BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520 | -29.6% | 13,777 | -15.0% | 0.00% | -40.0% |
| Q2 2023 | $739 | +26.5% | 16,215 | +12.6% | 0.01% | +25.0% |
| Q1 2023 | $584 | -18.9% | 14,400 | +2.0% | 0.00% | -20.0% |
| Q4 2022 | $720 | -99.9% | 14,123 | -22.5% | 0.01% | -37.5% |
| Q3 2022 | $982,000 | +75.7% | 18,225 | +109.4% | 0.01% | +100.0% |
| Q2 2022 | $559,000 | -12.0% | 8,703 | +6.3% | 0.00% | -20.0% |
| Q1 2022 | $635,000 | -3.1% | 8,184 | +7.2% | 0.01% | 0.0% |
| Q4 2021 | $655,000 | +0.3% | 7,635 | -5.8% | 0.01% | 0.0% |
| Q2 2021 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $653,000 | 0.0% | 8,107 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $653,000 | +510.3% | 8,107 | +398.9% | 0.01% | +66.7% |
| Q4 2018 | $107,000 | +28.9% | 1,625 | +50.7% | 0.00% | +50.0% |
| Q3 2018 | $83,000 | +16.9% | 1,078 | +11.8% | 0.00% | 0.0% |
| Q2 2018 | $71,000 | +16.4% | 964 | +3.0% | 0.00% | 0.0% |
| Q1 2018 | $61,000 | 0.0% | 936 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $61,000 | +1.7% | 936 | -2.8% | 0.00% | 0.0% |
| Q3 2017 | $60,000 | +20.0% | 963 | +16.7% | 0.00% | 0.0% |
| Q2 2017 | $50,000 | +16.3% | 825 | +0.4% | 0.00% | +50.0% |
| Q1 2017 | $43,000 | +7.5% | 822 | -8.7% | 0.00% | 0.0% |
| Q4 2016 | $40,000 | +11.1% | 900 | +18.9% | 0.00% | 0.0% |
| Q3 2016 | $36,000 | -81.5% | 757 | -84.1% | 0.00% | -88.2% |
| Q1 2016 | $195,000 | -92.7% | 4,751 | -93.2% | 0.02% | -93.5% |
| Q4 2015 | $2,684,000 | +17.8% | 70,351 | +1.4% | 0.26% | +14.4% |
| Q3 2015 | $2,278,000 | -46.6% | 69,351 | +13.6% | 0.23% | -44.1% |
| Q2 2015 | $4,269,000 | +57.2% | 61,051 | +54.0% | 0.41% | +49.1% |
| Q1 2015 | $2,716,000 | – | 39,651 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 41,000,000 | $2,482,140,000 | 22.00% |
| THUNDERBIRD PARTNERS LLP | 1,711,643 | $103,623,000 | 12.17% |
| SECTOR GAMMA AS | 1,070,333 | $64,798,000 | 9.42% |
| Veritas Asset Management LLP | 10,179,102 | $616,243,000 | 4.81% |
| 13D Management LLC | 194,807 | $11,794,000 | 4.18% |
| Progressive Investment Management Corp | 78,316 | $4,741,000 | 3.69% |
| Aristotle Capital Management, LLC | 6,846,307 | $414,476,000 | 3.46% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,394,075 | $84,397,000 | 3.37% |
| Lipe & Dalton | 80,073 | $4,848,000 | 3.14% |
| PURA VIDA INVESTMENTS, LLC | 125,000 | $7,568,000 | 3.00% |